Feedback / Questions
ARO-MMP7 - Arrowhead
ARO-MMP7: Initiation of P2 trial for IPF in 2024
(Arrowhead, 42nd Annual J.P. Morgan Healthcare Conference)
Jan 8, 2024
New P2 trial
•
Idiopathic Pulmonary Fibrosis
https://ir.arrowheadpharma.com/static-files/6bd2de78-6abd-4f2e-aaa0-3f297deae2c5
Jan 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious